Evidence map›Paper›PMID 34667177›Full record

ArticleNature communications2021

PHF3 regulates neuronal gene expression through the Pol II CTD reader domain SPOC.

Lisa-Marie Appel, Vedran Franke, Melania Bruno, Irina Grishkovskaya, Aiste Kasiliauskaite, Tanja Kaufmann, Ursula E Schoeberl, Martin G Puchinger, Sebastian Kostrhon, Carmen Ebenwaldner and 13 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 36 papers.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed
3.1field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 51 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Tumors and their microenvironments: Learning from pediatric brain pathologies.Biochimica et biophysica acta. Reviews on cancer · 2025
    Review
  9. Review
  10. Mechanism of mammalian transcriptional repression by noncoding RNA.Nature structural & molecular biology · 2025
    Article
  11. Article
  12. Liquid condensates: a new barrier to loop extrusion?Cellular and molecular life sciences : CMLS · 2025
    Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 8 institutions in 4 countries.

Lisa-Marie Appel *Department of Biochemistry and Cell Biology, Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Vienna, Austria.ORCID 0000-0002-6769-0777
Vedran Franke *The Berlin Institute for Medical Systems Biology, Max Delbrück Center, Berlin, Germany.ORCID 0000-0003-3606-6792
Melania Bruno *Department of Biochemistry and Cell Biology, Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Vienna, Austria.ORCID 0000-0002-8401-7744
Irina Grishkovskaya *Department of Structural and Computational Biology, Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Vienna, Austria.
Aiste KasiliauskaiteCEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
Tanja KaufmannDepartment of Biochemistry and Cell Biology, Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Vienna, Austria.ORCID 0000-0002-9734-260X
Ursula E SchoeberlNational Centre for Biomolecular Research, Faculty of Science, Masaryk University, Brno, Czech Republic.
Martin G PuchingerDepartment of Structural and Computational Biology, Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Vienna, Austria.
Sebastian KostrhonDepartment of Biochemistry and Cell Biology, Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Vienna, Austria.
Carmen EbenwaldnerDepartment of Biochemistry and Cell Biology, Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Vienna, Austria.
Marek SebestaCEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
Etienne BeltzungDepartment of Biochemistry and Cell Biology, Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Vienna, Austria.
Karl MechtlerResearch Institute of Molecular Pathology (IMP), Campus-Vienna-Biocenter 1, Vienna Biocenter (VBC), Vienna, Austria.ORCID 0000-0002-3392-9946
Gen LinResearch Institute of Molecular Pathology (IMP), Campus-Vienna-Biocenter 1, Vienna Biocenter (VBC), Vienna, Austria.
Anna VlasovaResearch Institute of Molecular Pathology (IMP), Campus-Vienna-Biocenter 1, Vienna Biocenter (VBC), Vienna, Austria.
Martin LeebDepartment of Microbiology, Immunobiology and Genetics, Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Vienna, Austria.ORCID 0000-0001-5114-4782
Rushad PavriResearch Institute of Molecular Pathology (IMP), Campus-Vienna-Biocenter 1, Vienna Biocenter (VBC), Vienna, Austria.
Alexander StarkResearch Institute of Molecular Pathology (IMP), Campus-Vienna-Biocenter 1, Vienna Biocenter (VBC), Vienna, Austria.ORCID 0000-0003-2611-0841
Altuna AkalinThe Berlin Institute for Medical Systems Biology, Max Delbrück Center, Berlin, Germany.ORCID 0000-0002-0468-0117
Richard SteflCEITEC-Central European Institute of Technology, Masaryk University, Brno, Czech Republic.
Carrie BerneckyInstitute of Science and Technology Austria (IST Austria), Am Campus 1, Klosterneuburg, Austria.ORCID 0000-0003-0893-7036
Kristina Djinovic-CarugoDepartment of Structural and Computational Biology, Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Vienna, Austria.ORCID 0000-0003-0252-2972
Dea SladeDepartment of Biochemistry and Cell Biology, Max Perutz Labs, University of Vienna, Vienna Biocenter (VBC), Vienna, Austria. dea.slade@maxperutzlabs.ac.at.ORCID 0000-0002-0052-5910
University of Vienna · ATResearch Institute of Molecular Pathology · ATCentral European Institute of Technology · CZMax Delbrück Center · DEInstitute of Molecular Biotechnology · ATInstitute of Science and Technology Austria · ATMasaryk University · CZMax Perutz Labs · AT

Funding

Austrian Science Fund FWF I 1593Austrian Science Fund FWF I 525Austrian Science Fund FWF P 31546Austrian Science Fund FWF T 795Wellcome Trust
6 · The paper itself

Abstract

The C-terminal domain (CTD) of the largest subunit of RNA polymerase II (Pol II) is a regulatory hub for transcription and RNA processing. Here, we identify PHD-finger protein 3 (PHF3) as a regulator of transcription and mRNA stability that docks onto Pol II CTD through its SPOC domain. We characterize SPOC as a CTD reader domain that preferentially binds two phosphorylated Serine-2 marks in adjacent CTD repeats. PHF3 drives liquid-liquid phase separation of phosphorylated Pol II, colocalizes with Pol II clusters and tracks with Pol II across the length of genes. PHF3 knock-out or SPOC deletion in human cells results in increased Pol II stalling, reduced elongation rate and an increase in mRNA stability, with marked derepression of neuronal genes. Key neuronal genes are aberrantly expressed in Phf3 knock-out mouse embryonic stem cells, resulting in impaired neuronal differentiation. Our data suggest that PHF3 acts as a prominent effector of neuronal gene regulation by bridging transcription with mRNA decay.

Indexed as

RNAAnimalsCell LineGene Expression RegulationGene Knockdown TechniquesHumansMiceMice, KnockoutNeuronsPhosphorylationProtein DomainsRNA Polymerase IIRNA Processing, Post-TranscriptionalRNA StabilityTranscription FactorsTranscription, GeneticPHF3 protein, humanRNARNA Polymerase IITranscription Factors

Identifiers

PMID34667177
PMCPMC8526623
OpenAlexW3207952997

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.